期刊文献+

MRI诊断前列腺疾病28例 被引量:1

MRI in diagnosis of prostate disease
原文传递
导出
摘要 目的探讨MRI对前列腺癌的临床诊断价值,分析漏诊、误诊原因以期提高MRI对前列腺癌的诊断符合率。方法回顾性分析28例临床拟诊前列腺疾患患者的MRI资料。结果本组28例患者经MRI诊断为前列腺癌24例,正确诊断率为85.7%,另外4例误诊为前列腺增生。误诊病例癌均发生在中央腺体,信号无明显差别。结论 MRI是前列腺癌及其分期最有效的影像手段,对临床治疗方法的选择具有重要指导意义。 Objective To evaluate the MRI on the diagnosis of prostate cancer,analysis of missed diagnosis and misdiagnosis in order to enhance the MRI diagnosis of prostate cancer rate.Methods A retrospective analysis of 28 cases diagnosed in patients with prostate disease MRI data.Results Totally 28 patients were diagnosed by MRI of prostate cancer in 24 cases,the correct diagnosis rate was 85.7%,other 4 cases were misdiagnosed as benign prostatic hyperplasia.Misdiagnosed cases of cancer occurred in the central gland,the signal was no significant difference.Conclusions MRI is a most effective imaging tool of staging of prostate cancer and have important guiding significance for clinical treatment.
作者 牛冬菊
出处 《医药论坛杂志》 2011年第4期86-88,共3页 Journal of Medical Forum
关键词 前列腺疾病 MRI 诊断 Prostate cancer MRI Diagnosis
  • 相关文献

参考文献7

  • 1Haider MA Chung P, Sweet J, et al. Dynamic contrasten - hanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy [J].Int J Radiat Oncol B iol Phys,2008,70 (2) :425- 430.
  • 2莫友发,李想良,高代平,张礼娟,涂昌灼,陈燕萍.前列腺癌的MRI诊断[J].实用放射学杂志,2007,23(7):936-939. 被引量:13
  • 3Cheikh AB Girouin N, Colombel M, et al. Evaluation of T2 -weighted and dynamic contrast- enhanced MRI in localizing prostate cancer before repeat biopsy [ J ]. Eur Radio1,2009,19 ( 3 ) :770-778.
  • 4Kim CK Park BK, Lee Hm, et al. MRI techniques for prediction of local tumor progression after high - intensity focused ultrasonic ablation of prostate cancer[ J]. A JR Am J Roentgenol, 2008,190 ( 5 ) : 1180-1186.
  • 5孔艳鹏,冯蕾.前列腺癌诊断方法的研究现状[J].中国介入影像与治疗学,2009,6(4):375-377. 被引量:14
  • 6Cheng HL, Haider MA, Dill - Macky M J, et al. MRI and contrast - enhanced ultrasound monitoring of prostate microwave focal thermal therapy:an in vivocanine study [J]. J Magn Reson Imaging,2008,28 (1) :136-143.
  • 7史浩,张广英,杨贞振,丁红宇.核磁共振动态增强扫描在前列腺癌诊断及鉴别诊断中的应用价值[J].中华老年医学杂志,2005,24(3):186-189. 被引量:14

二级参考文献32

  • 1张步林,胡兵.经直肠超声引导前列腺穿刺活检方案的合理选择[J].中国介入影像与治疗学,2007,4(1):71-75. 被引量:20
  • 2孟凡荣,陈松旺,张梅,李萍.前列腺移行区抗原密度诊断早期前列腺癌的价值[J].中国医学影像技术,2007,23(5):755-757. 被引量:4
  • 3Mitterberger M, Pinggera G, Horninger W, et al. Dutasteride prior to contrast enhanced color Doppler ultrasound prostate biopsy increases prostate cancer detection. Eur Urol, 2008, 53 (1) : 112 117.
  • 4Koike H, Tomita N, Azuma H, et al. An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J Gene Med, 2005,7(1):108 116.
  • 5Konig K, Scheipers U, Pesavento A, et al. Initial experiences with real time elastography guided biopsies of the prostate. J Urol, 2005,174(1):115-117.
  • 6Wefer AE, Hricak H, Vigneron DB, et al. Localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol, 2000, 164(2) :400- 404.
  • 7So MJ, Haker S, Zou KH, et al. Clinical evaluation of MR-guided prostate biopsy. Proceedings of the 13th Annual Meeting of ISMRM, Miami Beach, FL, USA, 2005 (Abstract 264).
  • 8Futterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology, 2006, 241 (2) : 449- 458.
  • 9Hara N, Okuizumi M, Koike H, et al. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate, 2005,62(2) :140-147.
  • 10Farsad M, Schiavina R, Castellucci P, et al. Detection and lo calization of prostate cancer: correlation of (ll)C-choline PET/ CT with histopathologic step-section analysis. J Nucl Med, 2005,46 (10) : 1642-1649.

共引文献35

同被引文献32

  • 1李飞宇,王霄英,丁建平,周良平,肖江喜,蒋学祥.良性前列腺增生的MRS与血清PSA、PSAD相关性初步研究[J].中国医学影像技术,2004,20(8):1164-1167. 被引量:7
  • 2李飒英,陈敏,周诚,陈锴.前列腺癌患者血清PSA与磁共振波谱代谢改变的相关性研究[J].临床放射学杂志,2006,25(9):855-857. 被引量:1
  • 3叶定伟,李长岭.前列腺癌发病趋势的回顾和展望[J].中国癌症杂志,2007,17(3):177-180. 被引量:119
  • 4Ferlay J,Parkin DM,Steliarova-Foucher E.Estimates of cancer incidence and mortality in Europe in 2008.Eur J Cancer,2010,46(4):765-781.
  • 5Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009.CA Cancer J Clin,2009,59 (4):225-249.
  • 6Cheikh AB,Girouin N,Colombel M,et al.Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy.Eur Radiol,2009,19(3):770-778.
  • 7Sushant V,Chavan,Niraj R,Chavan,Anusha Balaji,et al.A pilot study on the use of serum glyoxalase as a supplemental biomarker to predict malignant cases of the prostate in the PSA range of 4-20 ng/ml.Indian J Med Res,2011,134(4):458-462.
  • 8Thompson IM,Pauler DK,Goodman PJ,et al.Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4ng per milliliter.The New England Journal of Medicine,2004,350(22):2239-2246.
  • 9Chavan PR,Chavan SV,Chavan NR,Trivedi VD.Detection rate of prostate cancer using prostate specific antigen in patients presenting with lower urinary tract symptoms:a retrospective study.J Postgrad Med,2009(55):17-21.
  • 10Kim CK,Park B K,Lee Hm,et al.MRI techniques for prediction of local tumor progression after high-intensity focused ultrason icablation of prostate cancer.AJR Am J Roentgenol,2008,190(5):1180-1186.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部